Annual Net Income
-$328.07 M
-$88.59 M-36.99%
December 31, 2023
Summary
- As of February 7, 2025, RXRX annual net profit is -$328.07 million, with the most recent change of -$88.59 million (-36.99%) on December 31, 2023.
- During the last 3 years, RXRX annual net income has fallen by -$241.06 million (-277.06%).
- RXRX annual net income is now -430.17% below its all-time high of -$61.88 million, reached on December 31, 2019.
Performance
RXRX Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Net Income
-$95.84 M
+$1.70 M+1.74%
September 30, 2024
Summary
- As of February 7, 2025, RXRX quarterly net profit is -$95.84 million, with the most recent change of +$1.70 million (+1.74%) on September 30, 2024.
- Over the past year, RXRX quarterly net income has dropped by -$4.47 million (-4.89%).
- RXRX quarterly net income is now -420.20% below its all-time high of -$18.42 million, reached on March 31, 2020.
Performance
RXRX Quarterly Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM Net Income
-$377.75 M
-$2.83 M-0.75%
September 30, 2024
Summary
- As of February 7, 2025, RXRX TTM net profit is -$377.75 million, with the most recent change of -$2.83 million (-0.75%) on September 30, 2024.
- Over the past year, RXRX TTM net income has dropped by -$23.64 million (-6.68%).
- RXRX TTM net income is now -1950.32% below its all-time high of -$18.42 million, reached on March 31, 2020.
Performance
RXRX TTM Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Net Income Formula
Net Income = Revenue − COGS − Operating Expenses − Interest − Taxes − Other Expenses
RXRX Net Income Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -37.0% | -4.9% | -6.7% |
| 3 y3 years | -277.1% | -66.7% | -57.7% |
| 5 y5 years | -430.2% | -66.7% | -57.7% |
RXRX Net Income Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -75.9% | at low | -71.2% | +1.7% | -102.6% | at low |
| 5 y | 5-year | -430.2% | at low | -420.2% | +1.7% | -1950.3% | at low |
| alltime | all time | -430.2% | at low | -420.2% | +1.7% | -1950.3% | at low |
Recursion Pharmaceuticals Net Income History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$95.84 M(-1.7%) | -$377.75 M(+0.8%) |
| Jun 2024 | - | -$97.54 M(+6.7%) | -$374.93 M(+5.9%) |
| Mar 2024 | - | -$91.37 M(-1.7%) | -$354.11 M(+7.9%) |
| Dec 2023 | -$328.07 M(+37.0%) | -$93.00 M(-0.0%) | -$328.07 M(+12.1%) |
| Sep 2023 | - | -$93.02 M(+21.2%) | -$292.56 M(+12.5%) |
| Jun 2023 | - | -$76.73 M(+17.4%) | -$259.99 M(+4.5%) |
| Mar 2023 | - | -$65.33 M(+13.6%) | -$248.82 M(+3.9%) |
| Dec 2022 | -$239.48 M | -$57.49 M(-4.9%) | -$239.48 M(-3.0%) |
| Sep 2022 | - | -$60.45 M(-7.8%) | -$246.92 M(+5.6%) |
| Jun 2022 | - | -$65.56 M(+17.1%) | -$233.90 M(+10.5%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2022 | - | -$55.98 M(-13.8%) | -$211.74 M(+13.5%) |
| Dec 2021 | -$186.48 M(+114.3%) | -$64.93 M(+36.9%) | -$186.48 M(+26.6%) |
| Sep 2021 | - | -$47.43 M(+9.3%) | -$147.31 M(+19.0%) |
| Jun 2021 | - | -$43.40 M(+41.3%) | -$123.76 M(+24.6%) |
| Mar 2021 | - | -$30.72 M(+19.2%) | -$99.30 M(+14.1%) |
| Dec 2020 | -$87.01 M(+40.6%) | - | - |
| Dec 2020 | - | -$25.77 M(+7.9%) | -$87.01 M(+42.1%) |
| Sep 2020 | - | -$23.87 M(+26.0%) | -$61.24 M(+63.9%) |
| Jun 2020 | - | -$18.94 M(+2.8%) | -$37.37 M(+102.8%) |
| Mar 2020 | - | -$18.42 M | -$18.42 M |
| Dec 2019 | -$61.88 M | - | - |
FAQ
- What is Recursion Pharmaceuticals annual net profit?
- What is the all time high annual net income for Recursion Pharmaceuticals?
- What is Recursion Pharmaceuticals annual net income year-on-year change?
- What is Recursion Pharmaceuticals quarterly net profit?
- What is the all time high quarterly net income for Recursion Pharmaceuticals?
- What is Recursion Pharmaceuticals quarterly net income year-on-year change?
- What is Recursion Pharmaceuticals TTM net profit?
- What is the all time high TTM net income for Recursion Pharmaceuticals?
- What is Recursion Pharmaceuticals TTM net income year-on-year change?
What is Recursion Pharmaceuticals annual net profit?
The current annual net income of RXRX is -$328.07 M
What is the all time high annual net income for Recursion Pharmaceuticals?
Recursion Pharmaceuticals all-time high annual net profit is -$61.88 M
What is Recursion Pharmaceuticals annual net income year-on-year change?
Over the past year, RXRX annual net profit has changed by -$88.59 M (-36.99%)
What is Recursion Pharmaceuticals quarterly net profit?
The current quarterly net income of RXRX is -$95.84 M
What is the all time high quarterly net income for Recursion Pharmaceuticals?
Recursion Pharmaceuticals all-time high quarterly net profit is -$18.42 M
What is Recursion Pharmaceuticals quarterly net income year-on-year change?
Over the past year, RXRX quarterly net profit has changed by -$4.47 M (-4.89%)
What is Recursion Pharmaceuticals TTM net profit?
The current TTM net income of RXRX is -$377.75 M
What is the all time high TTM net income for Recursion Pharmaceuticals?
Recursion Pharmaceuticals all-time high TTM net profit is -$18.42 M
What is Recursion Pharmaceuticals TTM net income year-on-year change?
Over the past year, RXRX TTM net profit has changed by -$23.64 M (-6.68%)